This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Cell Cure Neurosciences Ltd. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Bat Shahaf - Innovator in Retinal Cell Therapy
Introduction
Bat Shahaf is an accomplished inventor based in Jerusalem, Israel. She has made significant contributions to the field of retinal cell therapy, focusing on innovative solutions for retinal degenerative diseases. Her work is characterized by a commitment to advancing medical treatments through her patented technologies.
Latest Patents
Bat Shahaf holds a patent for "Retinal pigment epithelium cell compositions." This patent presents ready-to-administer (RTA) retinal pigment epithelium (RPE) cell therapy compositions aimed at treating retinal degenerative diseases and injuries. The patent details a method for formulating human RPE cells for administration directly after thawing, as well as for cryopreservation. Additionally, it describes a thaw and inject (TAI) composition, allowing for injection after thawing.
Career Highlights
Bat Shahaf is associated with Cell Cure Neurosciences Ltd., where she continues to develop her innovative therapies. Her work at the company has positioned her as a key player in the advancement of retinal treatments.
Collaborations
Bat Shahaf collaborates with Ofer Wiser, contributing to the development of groundbreaking therapies in the field of retinal health.
Conclusion
Bat Shahaf's contributions to retinal cell therapy exemplify her dedication to innovation in medical science. Her patented work is paving the way for new treatments that could significantly improve the quality of life for individuals suffering from retinal diseases.